Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-26

FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Xtampza ER (oxycodone) from Collegium Pharmaceutical, Inc., marking an update to the product's labeling. The act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XTAMPZA ER (Oxycodone)

Snippet

SUPPL AP for XTAMPZA ER (OXYCODONE)